Omkar Pharmachem Ltd

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd has announced the voting results of its 31st AGM, where all resolutions were passed with majority. The resolutions included the adoption of audited financial statements, appointment of a director, and approval of material related party transactions.

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd held its 31st Annual General Meeting (AGM) on September 30, 2026, at Hotel Kanak, Ahmedabad. The meeting was chaired by Managing Director Bhawani S Goyal. The company received and adopted its audited financial statements for the year ended March 31, 2026, and appointed a new director. The meeting also considered and approved material related party transactions.

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd has announced the closure of its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half-year ended September 30, 2026.

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd has announced the submission of a newspaper publication under Regulation 47 of SEBI (LODR) Regulations, 2015 regarding the 31st Annual General Meeting of the Company. The AGM will be held on September 30, 2026, and the company has also made available the Annual Report along with the Notice convening the AGM on its website.

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd has fixed 23rd September 2026 as the record date for its 31st Annual General Meeting (AGM) and has arranged for electronic voting through Central Depository Services Limited (CDSL).

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd has submitted its 31st Annual Report for the financial year 2025-26, along with a notice of its 31st Annual General Meeting. The report includes audited financial statements, and the company is seeking approval for related party transactions with its Chief Financial Officer and Company Secretary.

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd has announced its 31st Annual General Meeting (AGM) to be held on September 30, 2026, to consider various business, including the appointment of a director, approval of related party transactions, and adoption of audited financial statements.

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd's board meeting on August 31, 2026, approved the notice for the 31st Annual General Meeting, related party transactions, and appointed a scrutinizer for the voting process.

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd has published its unaudited financial results for the quarter ended 30th June 2026. The company has announced its financial results in a newspaper advertisement.

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd has released its unaudited financial results for the quarter ended June 30, 2026, with a net loss of Rs. 1.00 lakhs. The company's revenue from operations was Rs. 9.00 lakhs, with other operating income of Rs. 9.00 lakhs. The company's expenses were Rs. 10.00 lakhs, resulting in a net loss of Rs. 1.00 lakhs. The earnings per share (EPS) before and after extraordinary items was Rs. 0.0099.

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd has announced its unaudited financial results for the quarter ended on 30th June 2026, with a net profit of Rs. 1.50 lakhs and earnings per share of Rs. 0.0099.

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 to consider and approve Unaudited Financial result for the quarter ended on June 30, 2026 along with Limited Review Report thereof.